Skip to main content
Scribing’s spending
To:Brew Readers
How AI scribes impact healthcare costs.
AdvertisementAdvertisementAdvertisement
August 07, 2026View Online | Sign Up | Shop
Newsletter Logo

Presented By

Sponsor Logo: HSBC

Happy Friday! Struggling to find a new healthcare job? Blame the economy. Healthcare and social assistance job openings fell by 147,000 in June, down to about 1.35 million, according to preliminary data from the US Bureau of Labor Statistics. It’s the biggest month-to-month drop in nearly a year.

In today’s edition:

🤖 Take note!

🩻 Recall Roundup

🏥 On Rotation

—Maia Anderson, Caroline Catherman

Tech

Highs and lows

Photo collage of a robot hand holding a colorful feather quill up in the air, with rectangles filled with handwritten notes behind it, and glowing glitch effects all around.

Morning Brew Inc, Photos: Unsplash

Ambient AI scribes have typically been marketed as tools to reduce providers’ administrative burden by speeding up the clinical documentation process. They may also be useful in boosting health system revenues.

Multiple studies show that scribe usage is leading to more billing codes being included in clinical notes, which in turn leads to higher reimbursement from insurers and higher revenues for hospitals. That may be a slight boon for health systems, experts said. But, they cautioned that it could also increase overall medical costs and insurance premiums, particularly when scribes are used in inpatient settings, which involve billing for much higher-cost services. Whether they also result in improvements in care is unclear.

“It leads us to a more interesting question, which is around who’s going to capture the benefits of AI as it disseminates throughout the healthcare system?” A Jay Holmgren, assistant professor at the University of California, San Francisco (UCSF), said.

Dig into the benefits and hidden costs of AI scribes here.—MA

Sponsored By HSBC

Midyear healthcare trends to watch

Sponsor: HSBC

Interested in new insights on funding, valuations, and strategies across healthcare? You’ll find comprehensive updates in HSBC Innovation Banking’s Mid-Year Healthcare Report.

The report delivers data-driven insights into investment trends, valuation shifts, and exit opportunities across biopharma and healthtech. You’ll see how risk appetite is shifting and where capital is concentrating.

Along the way, you’ll learn what it all means for founders, operators, and investors, and get a clearer picture about what the rest of 2026 could look like.

Discover what’s shaping the market and what may lie ahead. Get your copy of the report.

Tech

Devising change

medical devices

Illustration: Anna Kim, Photo: Adobe Stock

Welcome to Recall Roundup, our must-read for anyone who uses or purchases medical devices.

Each month, we compile a list of recent medical device removals and corrections the FDA has designated as Class I recalls. This class means the defect, if unaddressed, has a “reasonable probability” of seriously injuring or killing a patient, according to the agency’s website.

The July roundup commences here.—CC

Direct care

Ins and outs

On Rotation

Francis Scialabba

Wondering who’s in and who’s out at biopharmas, hospitals, and other healthcare companies? We’ve got you covered.

Welcome to July’s On Rotation, a monthly roundup of some of the leadership changes at healthcare companies, ranging from market leaders to newer startups.

Keep reading here.—CC

Sponsored By HSBC

Sponsor: HSBC

What’s next for healthcare investment? Healthcare investment is evolving. HSBC Innovation Banking’s Mid-Year Healthcare Report uncovers where capital is flowing, how valuations are shifting, and what emerging opportunities mean for founders, operators, and investors. Curious for those insights? Download your copy of the report.

vital signs

A laptop tracking vital signs is placed on rolling medical equipment.

Francis Scialabba

Today’s top healthcare reads.

Stat: $10 billion. That’s how much Medicaid spent on autism therapy in 2025, 5x the amount spent in 2021. Medicaid officials are urging states to add more guardrails. (the New York Times)

Quote: “This is not going to get better because of all the disease that’s already in the pipeline. These guys are being treated like disposable widgets, not human beings…We’re watching them die right before our eyes.”—Scott Laney, a National Institute for Occupational Safety and Health research epidemiologist, on persistently high rates of black lung disease among Appalachian coal miners (NPR)

Read: How nurses are helping trace and contain cyclosporiasis cases. (KFF Health News)

Checking healthcare’s vitals: From funding momentum to market uncertainty, healthcare is entering a new phase. HSBC Innovation Banking’s Mid-Year Healthcare Report provides timely insights into investment activity, valuations, and exits across healthcare. Take a look.*

*A message from our sponsor.

Twitter Facebook LinkedIn Instagram YouTube TikTok

Written by Maia Anderson and Caroline Catherman

Was this email forwarded to you? Sign up here.

Get smarter in just 5 minutes

Take The Brew to work

Interested in podcasts?

  • Check out ours here.
ADVERTISE//CAREERS//SHOP//FAQ

Update your email preferences or unsubscribe here.
View our privacy policy here.

Copyright © 2026 Morning Brew Inc. All rights reserved.
22 W 19th St, 4th Floor, New York, NY 10011

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew